With the wide application of parenteral nutrition (PN) and central venous catheter (CVC) in tumor patients, the relative infection led by CVC has become a common and troublesome hospital infection in clinics. During infusion, PN fluid forms a high-sugar and high-fat microenvironment around CVC, facilitating the adhesion, growth, and diffusion of pathogenic bacteria. This condition forms a bacterial biofilm (BF) consisting of one or several kinds of pathogenic bacteria. Upon formation of the film, pathogens in the BF can resist antibacterial drugs and immune cells, causing repeated infections of bacteria or fungi and endangering the lives of patients. In this article, we summarize the applications of PN, characteristics of CVC infection in tumor patients, mixed BF, and related research methods to provide reference for studies of mixed BF infection of CVC.
1 Clinical application and complications of PN
Clinical application of PN
PN refers to supplying a patient with water, calories (sugar and fat emulsion), amino acids (essential and non-essential), vitamins, and electrolytes through the venous pathway. This process is conducted to satisfy the basic nutritional requirements of patients [8] who cannot eat through the gastrointestinal tract and may also be applied to underfed patients to maintain normal nutritional status in intravenous infusion, promote wound healing, slow down weight loss, and ensure continuous growth for sick children. PN has been widely used since its introduction to clinics in the 1960s. In recent years, tolerance and safety of PN have been further improved with continuous improvement of nutrient solution formulation and infusion technology. PN not only provides effective nutritional support for critically ill patients and patients who cannot be ingest through the gastrointestinal tract but has also become an integral part of clinical treatment [9] . Currently, patients who benefit more from PN experience intestinal obstruction, short bowel syndrome, tumor cachexia, severe malnutrition, and metabolic diseases (such as severe burns and severe infections). Patients requiring PN in the short term correspond to those who have received gastrointestinal operation, those in perioperative period of major surgery, those with intestinal fistula, those who received assisted mechanical ventilator, and those with tumor cachexia.
Complications
Complications of PN include hyperglycemia, hyperlipidemia, hyperosmotic nonketotic acid intoxication coma, hypoglycemia, electrolyte disturbance, liver function injury, and infection [10] . In recent years, numerous studies have shown that long-term usage of PN and TPN can also lead to intestinal dysfunctions [11] , such as mucosal atrophy, immune dysfunction, and intestinal bacterial translocation, which are potential risk factors for systemic infection. Improving the function of the intestinal tract benefits tumor malignancy in patients [12] . In view of the abovementioned complications, people have gradually switched from single use of TPN to Enteral Nutrition (EN) + PN. Relevant studies have shown that the combination of EN + PN benefits patients with intestinal function (peristalsis, digestion, and absorption) in terms of recovery, sedimentation reduction in the cholesterol level, improvement in nutritional status and survival rate and effective shortening of patients' hospital stay [13] . For these reasons, adoption of EN is recommended as early as possible.
CVC-associated infection in tumor patients undergoing PN
During specific treatments, patients will inevitably be embedded with temporary or permanent fixture, such as catheters, tracheal intubation, surgical suture, titanium clip, titanium nail, drainage tube, and venous catheter [14] . Once patients become infected through an embedded material, bacteria and fungi will form bacterial/fungal BFs [15] . BFs comprise colonies of bacteria or fungi attached to the surface of living tissues.
BFs are encased in an extracellular matrix and exhibit definite structure and function. BFs are a unique form of life complex that differs among individuals and dispersed free-state microorganisms and are formed in the long-term evolution of bacterial cells to adapt to the environment [16] . Bacterial BFs can protect bacteria, increase their ability to develop resistance to antibiotics, and render ability to attack the body's immune system. This condition can lead to difficulties in treatment and relapse of infection, which can seriously affect the quality of life of patients and immune function and threaten the life of patients.
A number of studies have shown that tumor cells secrete a variety of immunosuppressive factors [17] , such as transformation growth factor-b 1 that evades immune system attacks, prostaglandin E 2 , vascular endothelial growth factor, interleukin (IL)-10, IL-6, IL-4, and cyclooxygenase-2. These immunosuppressive agents can reduce immunological and humoral immunity of tumor patients through various means, leading to low immune function. At the same time, the patient's immune function may be further damaged during surgery, chemotherapy, radiotherapy, and minimally invasive interventional therapy.
Almost all tumor patients must be repeatedly embedded with CVC [18] , especially those undergoing surgery and chemotherapy during tumor treatment to provide nutritional support in the long term. Infusion fluid and PN liquid form high-sugar and high-lipid microenvironment around the ducts in the blood vessel cavity, which benefits adhesion, growth, and diffusion of pathogenic bacteria on the surface of CVC and makes the area highly susceptible to bacterial infection. During treatment, a large number of broad-spectrum antibiotics are used, resulting in dissonance of flora and heterotopic conditions of pathogenic bacteria and subsequent formation of mixed bacterial-fungal BFs [3, 19] . Once mixed BFs are formed, difficulty in treatment significantly increases compared with single pathogenic bacteria BF, which requires at least a combination of antifungal and bacterial antibiotics. However, the effect is not optimal and further aggravates colony conditions, seriously affecting prognosis of patients.
Mixed BFs
Mixed bacteria-fungal infections form boundless BFs by competing adhesion sites, space, and nutrients [20] . In terms of coexistence, the organisms can be represented as antagonistic, cooperative, and symbiotic. In formation of mixed bacterial-fungal BFs, the most difficult part of clinical treatment is interaction and synergy of drugs used.
Two kinds of interaction exist between bacteria and fungi: (1) the physical support of surface structures (such as cell wall, mycelium, flagella, and cilia) [21] and (2) through interactions of secretion or autolysis chemicals (such as signaling molecules, extracellular polysaccharide, protein, and DNA and RNA) to complete the exchange and information transmission of genes and metabolites, change antibiotic resistance, adapt to environment pressures, and express virulence genes. Given the complexity of the interaction between bacteria and fungi, scarce information can explain the specific mechanisms, which must be further studied. After fully understanding such interactions, problems of infection, planting, and drug resistance can be potentially eradicated to effectively prevent and treat bacterial-fungal infection.
Effect of PN fluid in the formation of BF
As nutrient, PN fluid benefits growth of microorganisms and promotes formation of BF. In our preceding study, experimental methods, including crystal violet staining, half quantitative confocal laser scanning microscopy (CLSM), and electron microscopy, were used to study the influence of glucose with different concentrations on BF formation of Staphylococcus epidermidis; results showed that a high concentration of glucose benefits formation of bacterial BF [5] . Fat emulsion injection, another important component of PN, has become a common drug for patients with poor diet and malnutrition. In fat emulsion injection through CVC, high-lipid microenvironment forms in the local tubules and blood, where microorganisms, owing to the nutrients, easily grow. The existence of input materials of CVC causes the microorganisms to easily adhere and form BFs.
Studies have shown that fat emulsion significantly promotes growth of C. albicans and formation of hypha [7] . Electron microscopy and CLSM were adopted by Swindell et al. [6] to compare and observe fat emulsion (with different concentrations added to the nutrient solution) and nutrient solution groups; the researchers discovered that in the early stage of BF formation, germination of fat emulsion group and adherence of C. albicans increased. In middle and late stages of BF formation, the number of C. albicans was more complicated. Germination of fungi serves as an important factor of virulence. Fungal hyphae form an important skeletal component of BF, and experts speculate that fat milk will benefit formation of mixed C. albicans-bacteria BFs. However, no studies have reported the formation of mixed bacterial and fungal BFs.
Identification methods for mixed BFs
When infected with mixed bacteria, CVC is often used for bacterial culture and bacterial identification. Normally, three working days or longer are required for bacterial infection, including those of anaerobic bacteria. In this process, empirical antibiotic treatment is not only incapable of improving bacteremia of patients but can also actually worsen the disease. At present, fluorescence in situ hybridization (FISH) is the fastest strain identification method for bacteria.
Application of FISH in CVC infection presents advantages, such as being time saving, accurate, and visible via microscopy. However, it is relatively higher in terms of treatment cost [22, 23] . According to the common primers used in conservative areas of bacterial 16S rRNA and fungal 18S rRNA, FISH can identify the type of infectious bacteria via fluorescence labeling of different strains and observing via CLSM or fluorescence microscopy. Under normal conditions, the process of obtaining specimens to complete identification totals 2 h. Four steps can be adopted [24] : (1) fixation and penetration of bacteria, (2) hybridization, (3) sample washing, and (4) observation and identification.
Based on the microenvironment of bacterial BFs and studies on bacterial BFs with nutrient solution of different concentrations, we may discover effective methods of preventing BF formation by searching for appropriate infusion speed and concentration of nutrient solution. Some methods may avoid development of a high-sugar and high-lipid microenvironment, which benefits BF formation. Once BF is formed, FISH can be used in the early phase to rapidly and accurately identify the infected strains and develop an effective treatment regimen to control infection.
